Treatment of neovascular age-related macular degeneration: one year real-life results with intravitreal Brolucizumab

Treatment of neovascular age-related macular degeneration: one year real-life results with intravitreal Brolucizumab

BackgroundAge-related macular degeneration (AMD) is a prevalent cause of irreversible vision loss worldwide, particularly among the elderly population. Two forms of late AMD are described: neovascular AMD (nAMD), characterized by abnormal choroidal blood vessel growth, and atrophic (dry) AMD, involv...

Full description

Saved in:

Bibliographic Details
Main Authors:	Settimio Rossi, Carlo Gesualdo, Ernesto Marano, Raffaele Perrotta, Maria Consiglia Trotta, Antonio Del Giudice, Francesca Simonelli
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Frontiers in Medicine
Subjects:	age-related macular degeneration intravitreal injection brolucizumab real-life neovascularization
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2024.1467160/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Outcomes and predictive factors for fluid resolution following three loading injections of faricimab for treatment-naïve neovascular age-related macular degeneration
by: Hee Yong Han, et al.
Published: (2025-01-01)

Comparison of OCT Angiography Parameters after Administration of Intravitreal Brolucizumab versus Ranibizumab in Exudative Age-related Macular Degeneration
by: Sanjitha Vilma Moses, et al.
Published: (2024-12-01)

Global Insights from Patients, Providers, and Staff on Challenges and Solutions in Managing Neovascular Age-Related Macular Degeneration
by: Anat Loewenstein, et al.
Published: (2024-12-01)

Efficacy & safety of brolucizumab 6.0 mg versus 3.6 mg in diabetic macular edema
by: Sanjay Kumar Mishra, et al.
Published: (2025-01-01)

One-Year Outcomes in Subjects Developing Macular Neovascularization While Undergoing Avacincaptad Pegol Therapy for Geographic Atrophy
by: Rush RB, et al.
Published: (2025-01-01)

Intraocular inflammation after intravitreal injection of aflibercept 8 mg for treatment-refractory neovascular age-related macular degeneration: a case report
by: Nozomu Hashiya, et al.
Published: (2025-01-01)

Postpartum Exudation of Idiopathic Quiescent Macular Neovascularization: A Narrative Review with a Related Case Report
by: Livio Vitiello, et al.
Published: (2024-12-01)

12-month outcomes of ziv-aflibercept for neovascular age-related macular degeneration in eyes previously treated with aflibercept
by: Wajiha J Kheir, et al.
Published: (2025-01-01)

Predictive value of different baseline optical coherence tomography biomarkers for visual acuity changes in neovascular age-related macular degeneration
by: Hamid Riazi-Esfahani, et al.
Published: (2025-02-01)

A Review of Age-related Macular Degeneration and Current Concepts in Management
by: Sahebaan Sethi
Published: (2024-12-01)

Faricimab efficacy in type 1 macular neovascularization: AI-assisted quantification of pigment epithelium detachment (PED) volume reduction over 12 months in Naïve and switch eyes
by: Jennifer Cattaneo, et al.
Published: (2025-01-01)

Changes in Aqueous Humor Cytokine Profile Following Intravitreal Brolucizumab Injection
by: Ruamviboonsuk V, et al.
Published: (2025-02-01)

Intra-operative Intravitreal Bevacizumab For Patients With Diabetic Macular Edema Undergoing Phacoemulsification with Foldable IOL Implantation
by: Haider Ali Chaudhry, et al.
Published: (2024-06-01)

Suprachoroidal Versus Intravitreal Injection of Triamcinolone Acetonide As Primary Treatment For Diabetic Macular Edema
by: Fatima Shafqat Khan, et al.
Published: (2023-12-01)

Population Pharmacokinetics of Pegcetacoplan in Patients with Geographic Atrophy or Neovascular Age-related Macular Degeneration
by: Ryan L. Crass, PharmD, et al.
Published: (2025-03-01)

Anterior Segment Optical Coherence Tomography Evaluation of a Dexamethasone Intravitreal Implant in the Crystalline Lens: A Case Report
by: Santos-Oliveira J, et al.
Published: (2025-01-01)

Natural history of non-neovascular pigment epithelial detachments (PEDs): Comparison between serous and drusenoid PEDs
by: Mathilde M. Goudot, et al.
Published: (2025-04-01)

Dry and neovascular “wet” age-related macular degeneration: Upcoming therapies
by: Audrey Yan, et al.
Published: (2025-01-01)

Opportunities, challenges, and difficulties in NMR-based metabolomics applied to neovascular age-related macular degeneration (nAMD) patient follow-up
by: M. Schoumacher, et al.
Published: (2025-01-01)

Vitrectomy for full-thickness macular hole developed during aflibercept treatment for wet age-related macular degeneration
by: Agnieszka Nowosielska
Published: (2024-12-01)

Understanding the Impact of the Sirtuin 1 (SIRT1) Gene on Age-related Macular Degeneration: A Comprehensive Study
by: Saranya Velmurugan, et al.
Published: (2024-04-01)

How intravitreal anti-vascular endothelial growth factor initial dosing impacts patient outcomes in diabetic macular oedema
by: Rishi P. Singh, et al.
Published: (2024-12-01)

Role of ARMS2/HTRA1 risk alleles in the pathogenesis of neovascular age-related macular degeneration
by: Yang Pan, et al.
Published: (2024-12-01)

A comprehensive review on early detection of drusen patterns in age-related macular degeneration using deep learning models
by: Kiruthika M, et al.
Published: (2025-02-01)

The first experience with brolucizumab for neovascular age-related macular degeneration
by: A.N. Kulikov, et al.
Published: (2022-05-01)

EFFICIENT RETINAL IMAGE SEGMENTATION BY U-NET FOR AGE-RELATED MACULAR DEGENERATION DIAGNOSIS
by: S Sujatha, et al.
Published: (2024-12-01)

Real world pharmacovigilance assessment of drug related macular degeneration risks
by: Xiaodong Chen, et al.
Published: (2025-01-01)

Outer retina micro-inflammation is driven by T cell responses prior to retinal degeneration in early age-related macular degeneration
by: Lucas Stürzbecher, et al.
Published: (2025-02-01)

Could Infectious Agents Play a Role in the Onset of Age-related Macular Degeneration? A Scoping Review
by: Petra P. Larsen, MD, PhD, et al.
Published: (2025-03-01)

A cross-tissue transcriptome-wide association study identified susceptibility genes for age-related macular degeneration
by: Hongfan Yang, et al.
Published: (2025-02-01)

Therapeutic effect of dihydroartemisinin on Alzheimer’s disease model mice with senile macular degeneration
by: Gao Han, et al.
Published: (2025-02-01)

Intravitreal Brolucizumab for Choroidal Neovascularization Associated to Angioid Streaks
by: Somnath Chakraborty, et al.
Published: (2022-01-01)

Ibuprofen reduces inflammation, necroptosis and protects photoreceptors from light-induced retinal degeneration
by: Ping-Wu Zhang, et al.
Published: (2025-01-01)

Patients with Age-related Macular Degeneration Have Increased Susceptibility to Valvular Heart Disease
by: Natan Lishinsky-Fischer, et al.
Published: (2025-03-01)

Dosing intervals in Comparison of one-year real-world outcomes between red (670 nm) subthreshold micropulse laser treatment and intravitreal aflibercept injection for treatment-naïve diabetic macular edema
by: Kai Ching Peter Leung, et al.
Published: (2025-02-01)

Association between four anthropometric indices with age-related Macular Degeneration from NHANES 2005–2008
by: Chuyang Xu, et al.
Published: (2025-01-01)

Current advances in multimodal imaging in geographic atrophy secondary to age-related macular degeneration: A review
by: Amy C. Cohn, et al.
Published: (2024-12-01)

Targeted Therapy on Age-Related Macular Degeneration
by: Vankodoth Sireesha, et al.
Published: (2024-12-01)

Efficacy of a simple intravitreal perfluoropropane injection in treating unclosed idiopathic macular holes following vitrectomy
by: Zexia Dou, et al.
Published: (2025-02-01)

Modeling pegcetacoplan treatment effect for atrophic age-related macular degeneration with AI-based progression prediction
by: Irmela Mantel, et al.
Published: (2025-02-01)